In Patients Coinfected With HCV, HIV, Eradication Of HCV Had No Effect On Preclinical Atherosclerosis Markers Or Biomarkers Of Inflammation, Endothelial Dysfunction, Data Show

February 06, 2020

Infectious Disease Advisor (2/5, van Paridon) reports that “among patients coinfected with HIV and hepatitis C virus (HCV), eradication of HCV had no effect on markers of preclinical atherosclerosis and biomarkers of inflammation and endothelial dysfuncti...